No definition available.
Congenital malformations of posterior segment of eye
Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
181 |
4. Check minimum number of eventsNone |
181 |
5. Include endpoints |
181 |
6. Filter based on genotype QC (FinnGen only) |
181 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q1
- Name in latin
- Malformationes congenitae segmenti posterioris oculi
Similar endpoints
↥List of similar endpoints to
Congenital malformations of posterior segment of eye
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2267 | 918 | 1344 |
| Only index persons | 1896 | 773 | 1123 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.04 |
| Only index persons | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 18.62 | 21.64 | 16.46 |
| Only index persons | 25.83 | 31.39 | 22.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 181 | 91 | 90 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | 46.20 | 49.70 | 42.67 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 167
- Matched controls
- 1668
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q14.10
ICD-10 Finland
Congenital retinoschis
+∞
78.5
69
*
Q14.2
ICD-10 Finland
Congenital malformation of optic disc
+∞
42.5
39
*
Q14.8
ICD-10 Finland
Other congenital malformations of posterior segment of eye
+∞
34.6
32
*
H33.1
ICD-10 Finland
Retinoschisis and retinal cysts
119.3
20.1
21
*
Q14.18
ICD-10 Finland
Congenital malformation of retina
+∞
18.0
17
*
Z3229
NOMESCO Finland
Other healthcare associate professional
6.2
14.4
41
83
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.8
11.3
33
68
H53.0
ICD-10 Finland
Amblyopia ex anopsia
46.7
11.1
13
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
13.3
10.6
18
15
Q14.0
ICD-10 Finland
Congenital malformation of vitreous humour
+∞
10.5
10
*
XCK10
NOMESCO Finland
Photography of fundus of eye
5.0
10.0
33
78
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
58.5
9.8
11
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
58.5
9.8
11
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.3
9.6
37
103
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.5
8.8
46
164
Z2446
NOMESCO Finland
Social worker
4.4
8.0
29
76
H33.0
ICD-10 Finland
Retinal detachment with retinal break
10.2
8.0
15
16
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.1
7.4
29
82
Q13.0
ICD-10 Finland
Coloboma of iris
+∞
7.3
7
*
Q14.9
ICD-10 Finland
Congenital malformation of posterior segment of eye, unspecified
+∞
7.3
7
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.6
7.3
25
62
Z31.5
ICD-10 Finland
Genetic counselling
4.8
7.1
23
54
DFF00
NOMESCO Finland
Pure tone audiometry
4.1
6.9
26
71
UDC00
NOMESCO Finland
Ear microscopy
4.6
6.3
21
51
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.6
6.1
20
48
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037467) Urinalysis macro (dipstick) panel - Urine
126
957
2.04
4.64
5.4
4.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
79
529
1.88
4.07
8.3
8.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
79
2.72
3.78
11.8
8.8
%
0.9
1.3
1.05
20
79
(3024561) Albumin [Mass/volume] in Serum or Plasma
82
569
1.81
3.68
5.7
6.1
g/l
35.6
35.7
0.05
76
547
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
6
10.28
3.52
4.0
8.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
28
135
2.27
3.51
12.4
12.1
mmol/l
9.4
8.1
0.43
28
130
(3000991) Gas panel - Venous blood
32
168
2.10
3.26
27.8
9.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
33
3.48
3.25
17.5
15.4
%
72.4
66.4
0.51
11
33
(3024354) Oxygen [Partial pressure] in Venous blood
32
169
2.09
3.21
11.7
9.9
kpa
5.3
4.9
0.50
32
164
(3024928) Oxygen saturation in Venous blood
12
39
3.22
3.15
16.3
15.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
131
1074
1.80
3.08
7.6
7.6
u/l
85.3
92.4
0.83
126
1015
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
93
696
1.69
3.03
12.8
10.2
mmol/l
1.2
1.2
0.30
83
600
(3042733) HLA Ab [Presence] in Serum
5
5
10.23
2.99
6.6
2.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
23
110
2.25
2.94
9.0
7.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
41
3.06
2.92
2.5
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
33
183
1.98
2.90
12.7
10.4
mmol/l
1.0
1.6
0.34
28
149
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
88
655
1.67
2.89
4.0
4.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
344
1.76
2.86
2.7
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
53
345
1.76
2.83
4.7
4.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
34
195
1.92
2.71
3.5
2.8
g/l
2.4
2.4
0.09
34
181
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
44
2.85
2.60
2.5
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
40
247
1.80
2.53
3.9
3.7
e6/l
3.1
2.3
0.17
28
133
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
41
257
1.77
2.47
3.9
3.3
e6/l
1.5
0.8
0.67
29
144
(3003458) Phosphate [Moles/volume] in Serum or Plasma
37
225
1.81
2.46
13.4
9.3
mmol/l
1.2
1.2
0.34
37
213
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
51
342
1.68
2.42
6.3
3.4
ng/l
1612.8
1270.1
0.21
46
287
(3013826) Glucose [Moles/volume] in Serum or Plasma
106
853
1.59
2.37
12.0
6.3
mmol/l
6.6
6.6
0.04
98
792
(3020682) Albumin/Creatinine [Ratio] in Urine
54
371
1.65
2.33
4.7
4.0
mg/mmol
7.9
56.6
0.52
38
238
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
164
1484
2.12
2.32
15.6
14.0
mg/l
19.8
22.1
0.51
137
1119
(4035726)
22
114
2.06
2.32
1.6
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
68
497
1.59
2.28
9.0
7.4
inr
1.3
1.2
0.26
20
145
(3019198) Lymphocytes [#/volume] in Blood
100
802
1.55
2.21
7.5
7.8
e9/l
1.9
2.1
0.50
92
711
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
19
3.79
2.17
1.4
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
91
720
1.53
2.11
6.3
7.4
umol/l
12.6
11.3
0.24
86
691
(3007853) Bacteria identified in Skin by Aerobe culture
29
172
1.82
2.09
1.6
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
30
180
1.80
2.08
2.1
2.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
20
3.60
2.07
1.9
5.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
36
229
1.71
2.05
3.9
3.3
s
30.0
30.2
0.13
36
219
(3013650) Neutrophils [#/volume] in Blood by Automated count
108
890
1.53
2.05
10.2
11.3
e9/l
4.3
3.9
0.75
100
765
(3006315) Basophils [#/volume] in Blood
97
786
1.50
1.96
7.5
7.7
e9/l
0.0
0.0
0.05
88
671
(3001604) Monocytes [#/volume] in Blood
97
786
1.50
1.96
7.3
7.7
e9/l
0.6
0.6
0.32
87
671
(3013707) Erythrocyte sedimentation rate by Westergren method
126
1079
1.55
1.96
4.5
4.2
mm/h
13.0
11.0
0.63
120
1005
(3044640) Blood type and Crossmatch panel - Blood
61
448
1.55
1.96
2.7
2.7
—
—
—
0
0
(3009343) pH of Capillary blood
24
139
1.84
1.87
9.8
8.2
—
7.4
—
0
14
(40758558) Short blood count panel - Blood
57
417
1.54
1.85
5.0
7.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
23
132
1.85
1.84
34.1
11.4
mmol/l
1.2
1.3
0.24
23
126
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
12
4.25
1.83
1.2
2.4
u/ml
2154.6
767.3
—
5
12
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
12
4.25
1.83
1.2
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
24
140
1.82
1.83
9.8
8.2
kpa
5.3
5.0
1.11
24
129
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
47
330
1.57
1.82
2.4
2.6
mg/l
2.8
2.9
0.11
41
291
(3026782) Osmolality of Urine
42
287
1.60
1.82
4.1
3.2
mosm/kgh2o
583.5
551.4
0.29
37
239
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
26
156
1.78
1.81
33.1
14.0
mmol/l
25.3
25.1
0.09
26
156
(3018418) pH of Serum or Plasma
55
401
1.53
1.81
6.2
4.6
ph
7.4
7.4
—
8
80
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
74
2.12
1.81
2.4
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
57
419
1.53
1.81
4.4
3.6
e6/l
1.5
0.4
0.73
46
309
(3022948) Iron [Moles/volume] in Serum or Plasma
34
222
1.65
1.76
3.6
2.7
umol/l
13.7
13.3
0.12
34
207
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
24
2.99
1.74
1.4
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
57
423
1.51
1.72
4.5
3.6
mmol/l
6.8
8.2
1.88
52
364
(3013115) Eosinophils [#/volume] in Blood
97
801
1.45
1.70
8.1
8.1
e9/l
0.1
0.2
4.08
89
709
(3015377) Calcium [Moles/volume] in Serum or Plasma
59
443
1.49
1.68
3.3
3.5
mmol/l
2.4
2.4
0.35
52
398
(3011648) Oxygen content in Venous blood
6
19
3.23
1.67
14.7
25.0
%
11.7
12.2
—
6
19
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
64
493
1.46
1.59
2.0
1.8
pmol/l
100.0
95.5
0.32
36
255
(3013005) Retinol [Moles/volume] in Serum or Plasma
6
20
3.07
1.59
1.2
3.6
umol/l
1.5
1.6
—
6
20
(3012516) Albumin [Mass/volume] in Urine
48
350
1.51
1.56
4.1
3.1
mg/l
42.1
70.2
0.84
32
229
(3035637) Corticotropin [Mass/volume] in Plasma
8
33
2.49
1.55
2.3
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
32
213
1.61
1.54
2.5
1.8
—
—
—
0
0
(4010399)
17
94
1.89
1.53
1.4
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
15
3.40
1.53
1.0
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
83
680
1.41
1.45
3.8
3.8
estimate
0.0
0.0
0.00
12
129
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
22
2.78
1.44
1.5
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
22
2.78
1.44
1.5
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
60
2.07
1.41
46.1
18.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
59
457
1.43
1.41
4.4
3.8
e6/l
63.9
181.9
0.36
49
345
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
42
2.20
1.36
1.8
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
49
369
1.45
1.35
3.5
3.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
82
677
1.39
1.35
6.9
5.4
estimate
0.0
0.0
0.00
12
134
(3021960) Folate [Moles/volume] in Serum or Plasma
40
290
1.49
1.33
1.7
1.5
nmol/l
19.9
21.2
0.19
35
246
(3028626) Oxygen [Partial pressure] in Capillary blood
17
99
1.79
1.32
9.8
8.7
kpa
10.4
9.5
0.42
17
90
(3035285) Chloride [Moles/volume] in Venous blood
5
18
2.83
1.29
3.2
2.8
mmol/l
105.6
106.2
—
5
18
(3041354) Potassium [Moles/volume] in Venous blood
5
18
2.83
1.29
3.2
2.8
mmol/l
4.0
4.0
—
5
18
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
18
2.83
1.29
3.2
2.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
44
2.10
1.29
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
83
692
1.37
1.27
4.3
3.8
estimate
0.0
0.0
0.50
12
124
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
63
503
1.39
1.25
4.6
3.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
19
2.68
1.22
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
31
217
1.52
1.22
1.5
1.2
u/ml
25.5
7.3
0.50
13
80
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
207
0.55
1.19
1.0
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
137
1245
1.41
1.18
13.8
12.4
ml/min/173m2
81.7
83.9
0.49
119
973
(40761511) CBC panel - Blood by Automated count
164
1545
1.65
1.16
14.1
11.8
—
—
—
0
0
(3013512) EKG study
45
343
1.42
1.16
4.7
3.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
355
0.66
1.14
1.9
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
26
179
1.53
1.11
1.3
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
12
67
1.85
1.07
46.5
9.7
mmol/l
24.9
24.5
0.24
12
60
(3021589) Normoblasts [#/volume] in Blood
84
717
1.32
1.05
10.3
11.9
e9/l
0.0
0.0
0.36
71
566
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
39
296
1.40
1.03
2.9
2.5
mg/l
0.9
1.5
0.97
29
230
(3009542) Hematocrit [Volume Fraction] of Blood
151
1408
1.44
1.01
22.1
15.1
%
39.1
39.9
0.60
118
1123
(3019225) pH of Specimen
17
108
1.63
1.01
6.4
4.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
100
1.66
1.00
1.3
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
29
210
1.45
0.98
1.7
1.6
nmol/l
806.0
1269.1
2.90
23
167
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
117
1.60
0.98
2.8
4.0
ml/min/173m2
60.4
59.6
—
7
48
(3044889) 12 lead EKG panel
103
913
1.30
0.94
3.1
3.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
53
429
1.33
0.94
1.6
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
27
2.26
0.94
6.2
5.5
mmol/l
1.6
1.6
—
6
27
(3011397) Hemoglobin [Presence] in Urine by Test strip
43
337
1.36
0.94
3.6
3.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
142
1316
1.37
0.94
4.1
3.8
mmol/l
1.2
1.2
0.47
131
1217
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
52
1.77
0.94
4.1
2.2
ug/l
899.6
245.5
—
9
46
(36304419) Bacteria [Presence] in Urine
51
412
1.33
0.92
4.6
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
118
1070
1.30
0.88
3.7
3.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
12
72
1.71
0.87
1.9
2.0
iu/l
12.3
19.2
—
7
59
(3000492) Spirometry study
8
139
0.56
0.87
1.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
63
532
1.28
0.82
5.5
4.4
e6/l
18.1
59.8
1.16
47
362
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
123
1128
1.28
0.80
3.8
3.6
pmol/l
14.8
14.7
0.22
112
1036
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
66
1.71
0.80
6.7
7.3
%
57.9
51.3
0.44
11
66
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
144
1348
1.33
0.80
4.7
4.3
mu/l
1.9
2.8
0.50
136
1243
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
33
1.85
0.80
1.5
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
33
1.85
0.80
1.8
5.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
221
1.37
0.76
1.3
1.2
iu/ml
21.0
36.0
0.68
11
73
(40768804) Tissue Pathology biopsy report
60
510
1.26
0.73
1.6
2.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
26
1.95
0.71
5.0
5.7
mmol/l
7.7
7.3
—
5
26
(3052851) Hemolysis interference index of Serum or Plasma
7
42
1.69
0.69
1.4
3.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
322
0.74
0.67
2.6
1.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
44
1.61
0.66
1.7
3.7
mg/l
397.4
456.1
—
7
44
(3003740) Influenza virus B Ag [Presence] in Specimen
5
29
1.74
0.64
1.4
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
29
1.74
0.64
1.4
5.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
20
148
1.39
0.63
4.4
4.3
%
34.3
31.5
0.76
15
96
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
49
1.66
0.63
1.0
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
56
481
1.24
0.62
5.2
3.7
ng/l
133.5
37.8
0.47
44
314
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
30
1.69
0.62
2.2
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
30
1.69
0.62
1.0
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
30
1.69
0.62
1.4
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
80
1.54
0.61
1.6
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
52
1.56
0.60
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
52
1.56
0.60
1.9
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
64
1.60
0.60
7.5
4.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
64
1.60
0.60
1.4
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
18
133
1.39
0.57
2.7
4.4
e9/l
63.9
68.6
0.33
11
103
(3009214) Lutropin [Units/volume] in Serum or Plasma
11
73
1.54
0.57
2.3
2.0
u/l
4.0
6.1
—
6
55
(1761482) Bacteria [#/volume] in Urine by Culture
6
36
1.69
0.57
11.5
5.2
—
—
—
0
0
(1002224) Polysomnography panel
9
59
1.55
0.56
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
143
1359
1.25
0.55
4.6
4.1
mmol/l
1.5
1.5
0.23
132
1259
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
39
1.56
0.53
1.7
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
145
1.35
0.51
1.3
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
163
1.33
0.51
1.3
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
45
1.58
0.49
1.6
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
47
1.51
0.48
1.6
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
58
513
1.19
0.47
4.4
3.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
143
1367
1.22
0.47
4.7
4.2
mmol/l
4.6
4.6
0.58
132
1281
(3004588) Protein electrophoresis panel - Serum or Plasma
11
77
1.46
0.46
3.9
2.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
24
193
1.28
0.46
1.2
1.4
titre
493.3
428.1
—
6
37
(1761868) Lipid panel - Serum or Plasma
44
504
0.83
0.45
2.9
2.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
139
0.70
0.44
1.3
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
91
0.65
0.43
1.2
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
159
1.29
0.42
2.4
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
15
0.00
0.41
0.0
4.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
34
1.48
0.40
1.4
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
34
1.48
0.40
1.4
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
40
347
1.20
0.40
3.3
4.2
estimate
0.0
0.0
0.00
12
127
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
105
0.65
0.40
1.9
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
29
244
1.22
0.39
4.3
3.6
ng/l
246.1
229.0
0.03
22
180
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
35
1.44
0.39
2.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
113
0.69
0.38
1.0
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
36
311
1.20
0.38
3.2
2.7
e6/l
4.8
5.3
0.09
31
267
(3003338) MCHC [Mass/volume]
140
1345
1.18
0.38
20.4
17.3
g/l
333.4
333.9
0.25
140
1339
(3049717) Cytology report of Urine Cyto stain
6
43
1.41
0.35
2.5
2.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
132
1267
1.15
0.34
5.7
5.3
mmol/mol
39.1
39.6
0.24
124
1191
(3002256) Pathology report gross observation
13
165
0.77
0.33
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
47
1.29
0.32
1.0
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
52
1.36
0.31
3.4
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
18
148
1.24
0.30
6.3
20.4
inr
1.3
1.3
—
6
21
(3050129) First trimester maternal screen panel - Serum or Plasma
7
56
1.26
0.30
1.7
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
159
1.22
0.28
2.5
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
72
0.69
0.26
5.0
10.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
18
151
1.21
0.26
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
143
1390
1.14
0.25
5.3
4.6
mmol/l
2.7
2.8
0.85
132
1291
(3022621) pH of Urine by Test strip
12
96
1.27
0.25
4.8
2.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
82
0.72
0.24
1.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
97
1.25
0.23
2.7
3.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
41
1.23
0.22
1.0
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
198
0.84
0.22
1.3
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
10
0.00
0.21
0.0
4.8
—
44.2
—
0
10
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
1.1
—
0
12
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
6
48
1.26
0.20
3.7
1.7
—
84.0
—
0
7
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
49
1.23
0.20
3.5
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
49
1.23
0.20
6.2
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
49
1.23
0.20
3.5
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
51
1.18
0.19
1.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
58
1.22
0.18
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
36
391
0.90
0.18
1.6
1.6
g/l
1.8
2.1
0.44
19
220
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
67
0.74
0.17
1.8
2.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
140
0.85
0.16
3.7
7.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
79
1.15
0.15
3.0
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
35
377
0.91
0.15
1.7
1.8
mmol/l
1.2
1.4
0.70
30
329
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
96
0.83
0.14
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
35
326
1.09
0.13
2.8
5.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
147
0.88
0.12
1.3
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
14
124
1.14
0.11
5.9
2.0
g/l
3.3
1.2
0.41
14
117
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
319
1.08
0.11
4.2
4.2
%
21.8
22.8
0.16
15
147
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
115
1.14
0.11
1.8
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
166
0.89
0.10
1.4
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
12
106
1.14
0.10
2.8
5.2
mmol/l
1.2
1.2
0.43
12
98
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
135
1.12
0.10
1.5
3.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
5
45
1.11
0.10
1.4
2.0
ug/l
0.1
8.0
—
5
39
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
46
1.09
0.09
2.8
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
233
1.08
0.09
3.6
2.9
ug/l
0.7
0.8
0.25
15
149
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
267
0.93
0.09
2.2
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
55
1.09
0.09
3.2
3.8
u/ml
5.0
209.4
—
6
48
(3001019) Free T4 and TSH panel - Serum or Plasma
6
56
1.07
0.09
1.2
1.5
—
—
—
0
0
(3020891) Body temperature
6
57
1.05
0.08
9.5
5.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
63
0.79
0.08
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
86
1.05
0.07
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
90
0.88
0.07
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
152
0.91
0.06
1.3
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
11
121
0.90
0.06
4.1
4.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
39
376
1.05
0.05
4.9
3.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
90
1.12
0.05
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
36
348
1.04
0.04
3.8
3.5
umol/l
358.6
5045.1
1.26
36
307
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
200
0.94
0.04
2.4
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
16
151
1.07
0.03
2.5
3.5
g/l
0.2
0.2
0.22
16
142
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
132
1330
0.97
0.03
5.1
4.1
mmol/l
5.7
5.8
0.58
124
1232
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
15
157
0.95
0.01
6.7
4.7
u/l
227.9
246.0
0.43
15
152
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
163
1.05
0.01
1.9
2.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
16
154
1.04
0.00
7.6
3.2
g/l
13.3
9.6
0.34
16
145
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
41
406
1.01
0.00
1.4
1.6
u/ml
0.6
1.4
—
8
93
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
182
0.99
0.00
1.7
2.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
9.9
—
—
—
0
0
(3035880) pH of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
20.7
—
0
5
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
99.0
—
0
5
(3012565) Volume of 24 hour Urine
0
8
0.00
0.00
0.0
2.0
—
1955.6
—
0
8
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.5
—
45.5
—
0
8
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
13.0
—
0
5
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
25.3
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
51
0.98
0.00
1.2
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
67
0.89
0.00
1.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
67
0.89
0.00
1.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
66
0.91
0.00
1.0
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.8
—
4.6
—
0
6
(3010838) Calcium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
1497.5
—
0
6
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
64
0.94
0.00
1.0
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
7
0.00
0.00
0.0
1.0
—
166.3
—
0
7
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
65
0.92
0.00
1.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
67
0.89
0.00
1.0
1.4
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
17.6
—
8.9
—
0
7
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.6
—
207.9
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE | 1.133 [0.83, 1.54] | 0.424 |
| Birth year | 0.996 [0.99, 1.01] | 0.419 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 832 females with Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE | 0.919 [0.7, 1.21] | 0.544 |
| Birth year | 0.986 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 85 out of 1243 males with Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.1% | 0.158% |
| 5 | 0.631% | 0.93% |
| 10 | 1.739% | 2.363% |
| 15 | 3.15% | 4.483% |
| 20 | 5.696% | 7.972% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_POSTERI_SEGMENT_EYE – Congenital malformations of posterior segment of eye
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data